Not yet independently audited
This page was written from verified sources but has not yet passed the independent citation audit. Treat its claims as provisional.
PTSD clinical practice guidelines¶
TL;DR — Major guidelines converge on trauma-focused psychotherapy as first-line treatment but differ in grading, named protocols, medication hierarchy, nightmare treatment and the treatment of complex presentations. VA/DoD 2023 is anchored to its peer-reviewed synopsis (Schnurr 2024, PMID 38408360); NICE NG116 was re-fetched from nice.org.uk on 2026-09-02 (published 5 December 2018, with an April 2025 surveillance and a July 2026 exceptional surveillance listed on its evidence page). Guideline recommendations are not pooled effect estimates: they combine evidence, values, feasibility and grading rules. Mixed anxiety-disorder recommendations are not imported into PTSD.
Convergence¶
Trauma-focused psychotherapies—especially PE, CPT/trauma-focused cognitive therapies and EMDR—receive the strongest consistent support (Lewis 2020, PMID 32284821) (Cusack 2016, PMID 26574151).
VA/DoD 2023¶
The peer-reviewed synopsis records that subject experts from both departments developed 12 key questions, searched the literature by PICOTS, graded evidence with GRADE, and issued 34 recommendations across five topic areas — assessment and diagnosis, prevention, treatment, treatment of nightmares, and treatment of post-traumatic sleep disturbance (Schnurr 2024, PMID 38408360). A companion clinician's guide sets the recommendations alongside the clinical algorithm and shared-decision-making principles (Lang 2024, PMID 38184799). The update applied GRADE more strictly and evaluated named trauma-focused therapies individually rather than only as a class, so some modalities were downgraded without the underlying trials having changed.
NICE¶
NG116 covers recognition, assessment and treatment across ages and complex needs; it replaced CG26 and was published on 5 December 2018 (NICE NG116, https://www.nice.org.uk/guidance/NG116, accessed 2026-09-02). NICE's April 2025 surveillance found no new evidence requiring recommendation change. A July 2026 exceptional surveillance of NG116 — bundled with the autism (CG142, CG170) and ADHD (NG87) guidelines — is listed on the NG116 evidence page as of 2026-09-02; its decision document could not be retrieved in this session, so its outcome is recorded here as unknown rather than assumed, and is the first thing to check at the next sweep (NICE NG116 evidence page, accessed 2026-09-02). The guideline's pediatric drug evidence is a separate review from the adult drug evidence (National Guideline Alliance 2018, PMID 32757557).
ISTSS¶
The 2018 process included 361 RCTs and 208 meta-analyses, yielding 125 graded recommendations; most were insufficient evidence, reflecting evidence gaps rather than evidence of no effect (ISTSS, accessed 2026-09-02).
Medication¶
Guidelines generally rank trauma-focused psychotherapy above medication; sertraline and paroxetine remain the only two FDA-approved PTSD drugs, and neither medication alone nor combined pharmacotherapy-plus-psychotherapy is first-line in any published PTSD guideline (Rothbaum 2025, PMID 40308104) (Obi 2026, PMID 41792251). The VA/DoD guideline names prolonged exposure, cognitive processing therapy and EMDR as first-line; the American Psychological Association guideline names prolonged exposure, cognitive processing therapy, cognitive therapy and trauma-focused CBT — an example of guideline-level divergence in which named protocols are recommended, not in the class (Rothbaum 2025, PMID 40308104). Prazosin recommendations differ because nightmare evidence includes small positives and a large null trial (Raskind 2018, PMID 29414272).
CPTSD¶
Guidelines differ in whether and how they operationalise phase-based treatment. ICD-11 CPTSD validity evidence does not itself prove a specific sequence (Cloitre 2018, PMID 30178492) (Coventry 2020, PMID 32813696).
Implementation¶
A recommendation assumes trained clinicians, monitoring, patient choice and access. Absence of capacity can convert nominal first-line status into no treatment.
Quantitative anchors¶
| Measure | Estimate | Population/method | Source |
|---|---|---|---|
| VA/DoD | 2023 | 34 recommendations in 5 topic areas; 12 key questions; GRADE | (Schnurr 2024, PMID 38408360) |
| NICE NG116 | 2018; reviewed 2025 | Children, young people and adults | https://www.nice.org.uk/guidance/NG116 |
| ISTSS | 2018 | 125 recommendations from 361 RCTs/208 meta-analyses | https://istss.org/clinical-resources/trauma-treatment/ |
Evidence ledger¶
The ledger lists the live-retrieved records used to bound this page. Inclusion does not make every record equally probative; design, population and comparator remain decisive.
| PMID | Year | Evidence contribution | Scope caution |
|---|---|---|---|
| 32284821 | 2020 | Psychological therapies for post-traumatic stress disorder in adults: systematic review and meta-analysis. | Synthesis: preserve included-population and certainty limits |
| 26574151 | 2016 | Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis. | Synthesis: preserve included-population and certainty limits |
| 32063234 | 2020 | Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. | Synthesis: preserve included-population and certainty limits |
| 40308104 | 2025 | An Update on Psychotherapy for the Treatment of PTSD. | PTSD-specific record; inspect design and population |
| 29414272 | 2018 | Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans. | PTSD-specific record; inspect design and population |
| 12562588 | 2003 | Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. | PTSD-specific record; inspect design and population |
| 17069768 | 2007 | A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. | PTSD-specific record; inspect design and population |
| 30178492 | 2018 | The International Trauma Questionnaire: development of a self-report measure of ICD-11 PTSD and complex PTSD. | PTSD-specific record; inspect design and population |
| 32813696 | 2020 | Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis. | Synthesis: preserve included-population and certainty limits |
| 37132142 | 2024 | Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review. | Synthesis: preserve included-population and certainty limits |
| 39213321 | 2024 | Childhood trauma, PTSD/CPTSD and chronic pain: A systematic review. | Synthesis: preserve included-population and certainty limits |
| 39061119 | 2024 | Psychotherapeutic and pharmacological agents for post-traumatic stress disorder with sleep disorder: network meta-analysis. | Synthesis: preserve included-population and certainty limits |
| 37732560 | 2023 | Neurofeedback for post-traumatic stress disorder: systematic review and meta-analysis of clinical and neurophysiological outcomes. | Synthesis: preserve included-population and certainty limits |
| 34448406 | 2022 | Australian guidelines for the prevention and treatment of posttraumatic stress disorder: Updates in the third edition. | PTSD-specific record; inspect design and population |
| 38647566 | 2024 | Efficacy and acceptability of music therapy for post-traumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials. | Synthesis: preserve included-population and certainty limits |
| 26877093 | 2018 | 25 years of Eye Movement Desensitization and Reprocessing (EMDR): The EMDR therapy protocol, hypotheses of its mechanism of action and a systematic review of its efficacy in the treatment of post-traumatic stress disorder. | Synthesis: preserve included-population and certainty limits |
| 38408360 | 2024 | The Management of Posttraumatic Stress Disorder and Acute Stress Disorder: Synopsis of the 2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. | PTSD-specific record; inspect design and population |
| 36628572 | 2023 | Comparative effectiveness of psychotherapies in adults with posttraumatic stress disorder: a network meta-analysis of randomised controlled trials. | Synthesis: preserve included-population and certainty limits |
| 17728312 | 2007 | Post-traumatic stress disorder. | PTSD-specific record; inspect design and population |
| 28575815 | 2017 | Cardiac-disease-induced PTSD (CDI-PTSD): A systematic review. | Synthesis: preserve included-population and certainty limits |
| 28739068 | 2017 | Management of Emergence Delirium in Adult PTSD Patients: Recommendations for Practice. | PTSD-specific record; inspect design and population |
| 32372541 | 2020 | Post-traumatic stress disorder in nurses: An integrative review. | Synthesis: preserve included-population and certainty limits |
| 33766192 | 2021 | Post-traumatic Stress Disorder in Middle Age and Beyond. | PTSD-specific record; inspect design and population |
| 36367112 | 2023 | Toward staging differentiation for posttraumatic stress disorder treatment. | PTSD-specific record; inspect design and population |
| 32448255 | 2020 | Occupational post-traumatic stress disorder: an updated systematic review. | Synthesis: preserve included-population and certainty limits |
| 38533796 | 2024 | Digital-Based Interventions for Complex Post-Traumatic Stress Disorder: A Systematic Literature Review. | Synthesis: preserve included-population and certainty limits |
| 30261912 | 2018 | Posttraumatic stress disorder: from diagnosis to prevention. | PTSD-specific record; inspect design and population |
| 31781875 | 2019 | The Interaction Between Chronic Pain and PTSD. | PTSD-specific record; inspect design and population |
| 38184799 | 2024 | A clinician's guide to the 2023 VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder. | Implementation guidance, not new evidence |
| 32757557 | 2018 | Evidence reviews for pharmacological interventions for the prevention and treatment of PTSD in children: Post-traumatic stress disorder: Evidence review E. | Guideline evidence review; children only |
| 41792251 | 2026 | Investigational drugs in PTSD. | Narrative review; records current approvals and pipeline |
Interpretation guardrails¶
- Trauma exposure, post-traumatic symptoms, acute stress disorder, DSM-5 PTSD, ICD-11 PTSD and ICD-11 complex PTSD are not interchangeable populations.
- A mixed-anxiety or transdiagnostic estimate is labelled as such; only a source’s PTSD stratum can be treated as a PTSD effect.
- Comorbid depression is measured separately and cross-linked to the depression condition; it is not absorbed into PTSD.
- Waitlist, treatment-as-usual, attention control and active treatment answer different causal questions.
- Registration, statistical significance and diagnostic loss do not respectively prove completion, clinical importance or functional recovery.
- This page synthesizes research and does not provide individual medical advice.
Minimum extraction frame for studies on this topic¶
| Field | What must be retained | Why it changes interpretation |
|---|---|---|
| Diagnostic system | DSM version, ICD version, full/subthreshold | Case mix is not interchangeable |
| Diagnostic method | Structured interview, clinician judgment, self-report cutoff | Screening is not diagnosis |
| Index trauma | Type, timing, repetition, direct/indirect/occupational | Conditional risk and phenotype differ |
| Population | Civilian, veteran, refugee, child/adolescent, mixed | Transportability is empirical |
| Baseline severity | Mean, SD, range and exclusion threshold | Ceiling and floor effects alter change |
| CPTSD status | ITQ/ICD-11 definition and DSO score | Complexity cannot be inferred from trauma count |
| Comorbidity | Depression, GAD, SUD, pain, TBI measured separately | Shared symptoms can distort effects |
| Comparator | Waitlist, usual care, attention, active treatment | The estimand changes with comparator |
| Treatment dose | Sessions offered/attended, duration, homework | Assignment is not exposure |
| Outcome | Symptoms, diagnosis, response, function, sleep | Outcomes are not interchangeable |
| Time point | End point and prespecified follow-up windows | Acute benefit may not persist |
| Missing data | Denominator, reasons, imputation and estimand | Attrition can bias rank and magnitude |
| Adverse events | Definitions, ascertainment and arm-level counts | Absence of reporting is not absence of harm |
| Therapist/context | Training, fidelity, allegiance, setting | Delivery is part of the intervention |
| Funding/conflicts | Sponsor role and analytic independence | Especially material for proprietary packages |
Claims this page does not make¶
- It does not infer PTSD from trauma exposure alone.
- It does not treat a self-report cutoff as equivalent to a structured diagnosis.
- It does not convert a pooled anxiety-disorder effect into a PTSD effect.
- It does not convert a depression outcome in a comorbid sample into a PTSD outcome.
- It does not infer superiority from a statistically significant within-group change.
- It does not infer equivalence from a non-significant between-group test.
- It does not infer effectiveness from trial registration or mechanistic plausibility.
- It does not assume military, civilian, refugee and pediatric estimates transport unchanged.
- It does not average conflicting estimates that use different definitions.
- It does not treat lack of adverse-event reporting as evidence of safety.
Evidence-updating triggers¶
| Trigger | Required response |
|---|---|
| New diagnostic revision | Recalculate which populations prior estimates represent |
| New head-to-head RCT | Compare against active treatment, not only waitlist |
| New individual-participant synthesis | Revisit effect modifiers and transportability |
| Registry status change | Verify results and linked publication before changing conclusions |
| Guideline update | Separate evidence review from panel recommendation |
| Regulatory decision | Record decision date and source; do not infer from efficacy papers |
| Safety signal | Re-extract denominator, ascertainment and exposure time by arm |
| Contradictory replication | Display estimates side by side; do not average definitions |
Evidence updates should preserve the prior estimate and explain why the new study changes—or does not change—the inference.
Open questions¶
- Can guideline panels harmonise outcome thresholds and evidence-grading decisions transparently? (Mavranezouli 2020, PMID 32063234)
- How should guideline recommendations incorporate retention-adjusted benefit? (Harper 2026, PMID 41926191)
- What evidence would justify CPTSD-specific sequencing recommendations? (Cloitre 2018, PMID 30178492) (Coventry 2020, PMID 32813696)
Related pages¶
- comparative-psychotherapy-evidence — evidence beneath recommendations.
- pharmacotherapy — drug hierarchy.
- complex-ptsd — phase-based controversy.
- clinical-trials-landscape — evidence likely to change guidance.
References¶
- Lewis C, et al. Psychological therapies for post-traumatic stress disorder in adults: systematic review and meta-analysis. Eur J Psychotraumatol. 2020;11(1):1729633. PMID 32284821
- Cusack K, et al. Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Clin Psychol Rev. 2016;43:128-41. PMID 26574151
- Mavranezouli I, et al. Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Psychol Med. 2020;50(4):542-555. PMID 32063234
- Rothbaum BO, et al. An Update on Psychotherapy for the Treatment of PTSD. Am J Psychiatry. 2025;182(5):424-437. PMID 40308104
- Raskind MA, et al. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans. N Engl J Med. 2018;378(6):507-517. PMID 29414272
- Raskind MA, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003;160(2):371-3. PMID 12562588
- Raskind MA, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007;61(8):928-34. PMID 17069768
- Cloitre M, et al. The International Trauma Questionnaire: development of a self-report measure of ICD-11 PTSD and complex PTSD. Acta Psychiatr Scand. 2018;138(6):536-546. PMID 30178492
- Coventry PA, et al. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis. PLoS Med. 2020;17(8):e1003262. PMID 32813696
- Burback L, et al. Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review. Curr Neuropharmacol. 2024;22(4):557-635. PMID 37132142
- Karimov-Zwienenberg M, et al. Childhood trauma, PTSD/CPTSD and chronic pain: A systematic review. PLoS One. 2024;19(8):e0309332. PMID 39213321
- Huang CY, et al. Psychotherapeutic and pharmacological agents for post-traumatic stress disorder with sleep disorder: network meta-analysis. Ann Med. 2024;56(1):2381696. PMID 39061119
- Askovic M, et al. Neurofeedback for post-traumatic stress disorder: systematic review and meta-analysis of clinical and neurophysiological outcomes. Eur J Psychotraumatol. 2023;14(2):2257435. PMID 37732560
- Phelps AJ, et al. Australian guidelines for the prevention and treatment of posttraumatic stress disorder: Updates in the third edition. Aust N Z J Psychiatry. 2022;56(3):230-247. PMID 34448406
- Ma YM, et al. Efficacy and acceptability of music therapy for post-traumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials. Eur J Psychotraumatol. 2024;15(1):2342739. PMID 38647566
- Novo Navarro P, et al. 25 years of Eye Movement Desensitization and Reprocessing (EMDR): The EMDR therapy protocol, hypotheses of its mechanism of action and a systematic review of its efficacy in the treatment of post-traumatic stress disorder. Rev Psiquiatr Salud Ment (Engl Ed). 2018;11(2):101-114. PMID 26877093
- Schnurr PP, et al. The Management of Posttraumatic Stress Disorder and Acute Stress Disorder: Synopsis of the 2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Ann Intern Med. 2024;177(3):363-374. PMID 38408360
- Yunitri N, et al. Comparative effectiveness of psychotherapies in adults with posttraumatic stress disorder: a network meta-analysis of randomised controlled trials. Psychol Med. 2023;53(13):6376-6388. PMID 36628572
- Bisson JI Post-traumatic stress disorder. Occup Med (Lond). 2007;57(6):399-403. PMID 17728312
- Vilchinsky N, et al. Cardiac-disease-induced PTSD (CDI-PTSD): A systematic review. Clin Psychol Rev. 2017;55:92-106. PMID 28575815
- Lovestrand D, et al. Management of Emergence Delirium in Adult PTSD Patients: Recommendations for Practice. J Perianesth Nurs. 2017;32(4):356-366. PMID 28739068
- Schuster M, et al. Post-traumatic stress disorder in nurses: An integrative review. J Clin Nurs. 2020;29(15-16):2769-2787. PMID 32372541
- Marshall LL, et al. Post-traumatic Stress Disorder in Middle Age and Beyond. Sr Care Pharm. 2021;36(4):191-207. PMID 33766192
- Nijdam MJ, et al. Toward staging differentiation for posttraumatic stress disorder treatment. Acta Psychiatr Scand. 2023;147(1):65-80. PMID 36367112
- Lee W, et al. Occupational post-traumatic stress disorder: an updated systematic review. BMC Public Health. 2020;20(1):768. PMID 32448255
- Blackie M, et al. Digital-Based Interventions for Complex Post-Traumatic Stress Disorder: A Systematic Literature Review. Trauma Violence Abuse. 2024;25(4):3115-3130. PMID 38533796
- Miao XR, et al. Posttraumatic stress disorder: from diagnosis to prevention. Mil Med Res. 2018;5(1):32. PMID 30261912
- Kind S, et al. The Interaction Between Chronic Pain and PTSD. Curr Pain Headache Rep. 2019;23(12):91. PMID 31781875
- Harper KL, et al. Comparing dropout from cognitive processing therapy versus prolonged exposure: Results from a randomized clinical trial. J Consult Clin Psychol. 2026;94(3):140-150. PMID 41926191
- Lang AJ, et al. A clinician's guide to the 2023 VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder. J Trauma Stress. 2024;37(1):19-34. PMID 38184799
- National Guideline Alliance (UK). Evidence reviews for pharmacological interventions for the prevention and treatment of PTSD in children: Post-traumatic stress disorder: Evidence review E. London: NICE; 2018. PMID 32757557
- Obi T, Ressler KJ. Investigational drugs in PTSD. Neuropsychopharmacology. 2026;51(7):1147-1160. PMID 41792251